Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites
暂无分享,去创建一个
H. Vilstrup | G. Dam | P. Jepsen | H. Watson
[1] C. Tovo,et al. Proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhosis: An undesirable association? , 2015, Journal of hepatology.
[2] F. Barreyro,et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. , 2015, Journal of hepatology.
[3] K. Reddy,et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] B. Kronenberger,et al. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis , 2015, Alimentary pharmacology & therapeutics.
[5] S. Taylor-Robinson,et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[6] P. Hu,et al. Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure , 2014, Hepatitis monthly.
[7] D. Shawcross,et al. Recent insights into the pathogenesis of hepatic encephalopathy and treatments , 2014, Expert review of gastroenterology & hepatology.
[8] P. Deltenre,et al. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[9] H. Vilstrup,et al. Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development , 2013, Metabolic Brain Disease.
[10] Adrian V. Hernández,et al. Acid‐suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta‐analysis , 2013, Journal of gastroenterology and hepatology.
[11] K. Lapane,et al. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis , 2012, Alimentary pharmacology & therapeutics.
[12] D. Adler,et al. Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis , 2012, The American Journal of Gastroenterology.
[13] D. van Duin,et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] Ronald B. Geskus,et al. ipw: An R Package for Inverse Probability Weighting , 2011 .
[15] A. Gerbes,et al. Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity , 2011, Gut.
[16] Kyeong Ok Kim,et al. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites , 2011, Scandinavian journal of gastroenterology.
[17] Y. Chawla,et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. , 2010, Journal of hepatology.
[18] A. Sanyal,et al. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy , 2009, Hepatology.
[19] R. Hoffmann,et al. Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites , 2009, The American Journal of Gastroenterology.
[20] N. Chavez-Tapia,et al. Use and overuse of proton pump inhibitors in cirrhotic patients. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[21] K. Obstein,et al. Association between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis , 2008, Digestive Diseases and Sciences.
[22] M. Hernán,et al. Controlling for Time-dependent Confounding using Marginal Structural Models , 2004 .
[23] G. Satten,et al. Estimation of Integrated Transition Hazards and Stage Occupation Probabilities for Non‐Markov Systems Under Dependent Censoring , 2002, Biometrics.
[24] R Fischer,et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? , 2000, Journal of hepatology.
[25] A. Nakahara,et al. [Proton-pump inhibitor]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.
[26] L. Ranek,et al. Splanchnic galactose uptake in patients with cirrhosis during continuous infusion. , 1983, Clinical physiology.
[27] S. Sherlock,et al. The bacterial content of the small intestine in normal and cirrhotic subjects: relation to methionine toxicity. , 1957, Clinical science.